Kant K S, Glueck H I, Coots M C, Tonne V A, Brubaker R, Penn I
Department of Medicine-Nephrology, College of Medicine, University of Cincinnati, OH.
Am J Kidney Dis. 1992 Mar;19(3):264-71. doi: 10.1016/s0272-6386(13)80008-x.
Skin necrosis associated with protein C deficiency has recently been reported to occur in hemodialysis patients. The clinical presentation and course of this syndrome appears indistinguishable from skin necrosis (purpura fulminans) seen in other settings with inherited or acquired deficiency of the naturally occurring anticoagulant proteins, protein C and S. Patients on maintenance hemodialysis may have low levels of these factors. However, patients on peritoneal dialysis have normal or elevated levels of these proteins despite documented peritoneal losses. We report two patients in whom the occurrence of protein S deficiency and subsequent skin necrosis can be related to demonstrated peritoneal dialysis-associated losses. We suggest that these losses may become critical under appropriate conditions and suggest caution in peritoneal dialysis patients requiring warfarin therapy.
近期有报道称,血液透析患者会出现与蛋白C缺乏相关的皮肤坏死。该综合征的临床表现及病程似乎与在其他遗传性或获得性天然抗凝蛋白(蛋白C和蛋白S)缺乏情况下出现的皮肤坏死(暴发性紫癜)并无二致。维持性血液透析患者的这些因子水平可能较低。然而,腹膜透析患者尽管有腹膜丢失的记录,但这些蛋白水平正常或升高。我们报告了两名患者,其蛋白S缺乏及随后的皮肤坏死发生可能与已证实的腹膜透析相关丢失有关。我们认为,在适当条件下这些丢失可能变得至关重要,并建议对需要华法林治疗的腹膜透析患者予以谨慎对待。